基于超声造影的人工智能模型用于局灶性肝脏病变的多分类
该研究自2017年1月至2023年12月从52个中心收集成人>1 cm实性局灶性肝脏病变的超声造影视频、免疫组化标志物和临床信息,构建并验证基于超声造影的人工智能模型Model-DCB,用于六类病变分类。在三个外部测试集中,Model-DCB准确率0.85至0.86,显著优于初级超声造影放射科医生(0.59-0.73),与高级超声造影放射科医生(0.79-0.85)和高级MRI放射科医生(0.82-0.86)相当。
要点
- Model-DCB在外部测试集A、B、C的准确率为0.85至0.86。
- 初级超声造影放射科医生准确率为0.59-0.73。
- 高级MRI放射科医生准确率为0.82-0.86。
核心结论
- 基于超声造影的Model-DCB可对局灶性肝脏病变进行准确多分类;作者认为其有望适用于广泛人群,尤其是难以获得MRI的偏远地区人群。
研究设计与样本
- 研究自2017年1月至2023年12月从52个中心收集成人>1 cm实性局灶性肝脏病变的超声造影视频、免疫组化标志物和临床信息,用于构建和测试模型。
- 模型将局灶性肝脏病变分为六类:肝细胞癌、肝转移、肝内胆管癌、肝血管瘤、肝脓肿和其他。
- 先在训练集A和验证集中构建Module-Disease、Module-Biomarker和Module-Clinic,再将三个模块聚合为Model-DCB,在训练集B和内部测试集中评估。
- 在三个外部测试集中将Model-DCB与超声造影和MRI放射科医生进行比较。
- 共纳入来自52个中心的3725个局灶性肝脏病变,分为训练集A(n=2088)、验证集(n=592)、训练集B(n=234)、内部测试集(n=110)和外部测试集A(n=113)、B(n=276)、C(n=312)。
主要发现
- 在外部测试集A、B和C中,Model-DCB准确率为0.85至0.86,显著优于初级超声造影放射科医生(0.59-0.73)。
- 在外部测试集A、B和C中,Model-DCB与高级超声造影放射科医生(0.79-0.85)和高级MRI放射科医生(0.82-0.86)表现相当。
- 在人口学特征、肿瘤特征和超声设备的多项亚组分析中,Model-DCB准确率为0.79至0.92。
临床怎么用
- 作者认为,超声设备、超声造影检查和Model-DCB的结合可使偏远地区患者通过初级放射科医生的检查获得准确诊断。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Accurate multi-classification is a prerequisite for appropriate management of focal liver lesions (FLLs). Ultrasound is the most common imaging examination but lacks accuracy. Contrast-enhanced ultrasound (CEUS) offers better performance but is highly dependent on operator experience. Therefore, we aimed to develop a CEUS-based artificial intelligence (AI) model for FLL multi-classification and evaluate its performance in multicenter clinical tests. METHODS: Since January 2017 to December 2023, CEUS videos, immunohistochemical biomarkers and clinical information on solid FLLs >1 cm in adults were collected from 52 centers to build and test the model. The model was developed to classify FLLs into six types: hepatocellular carcinoma, hepatic metastasis, intrahepatic cholangiocarcinoma, hepatic hemangioma, hepatic abscess and others. First, Module-Disease, Module-Biomarker and Module-Clinic were built in training set A and a validation set. Then, three modules were aggregated as Model-DCB in training set B and an internal test set. Model-DCB performance was compared with CEUS and MRI radiologists in three external test sets. RESULTS: In total 3,725 FLLs from 52 centers were divided into training set A (n = 2,088), the validation set (n = 592), training set B (n = 234), the internal test set (n = 110), and external test sets A (n = 113), B (n = 276) and C (n = 312). In external test sets A, B and C, Model-DCB achieved significantly better performance (accuracy from 0.85 to 0.86) than junior CEUS radiologists (0.59-0.73), and comparable performance to senior CEUS radiologists (0.79-0.85) and senior MRI radiologists (0.82-0.86). In multiple subgroup analyses on demographic characteristics, tumor characteristics and ultrasound devices, its accuracy ranged from 0.79 to 0.92. CONCLUSIONS: CEUS-based Model-DCB provides accurate multi-classification of FLLs. It holds promise for a wide range of populations, especially those in remote areas who have difficulty accessing MRI. CLINICAL TRIAL: NCT04682886. IMPACT AND IMPLICATIONS: Ultrasound is the most common imaging examination for screening focal liver lesions (FLLs), but it lacks accuracy for multi-classification, which is a prerequisite for appropriate clinical management. Contrast-enhanced ultrasound (CEUS) offers better diagnostic performance but relies on the experience of radiologists. We developed a CEUS-based model (Model-DCB) that can help junior CEUS radiologists to achieve comparable diagnostic ability as senior CEUS radiologists and senior MRI radiologists. The combination of an ultrasound device, CEUS examination and Model-DCB means that even patients in remote areas can be accurately diagnosed through examination by junior radiologists.
引用
- Ding W, Meng Y, Ma J, et al. Contrast-enhanced ultrasound-based AI model for multi-classification of focal liver lesions. J Hepatol. 2025. PMID: 39848548. doi:10.1016/j.jhep.2025.01.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。